Biogen exits biosimilar JV with Samsung, raising $2.3bnRecent rumours that Biogen was about to acquired by Samsung proved unfounded, but it turns out a deal Share XBiogen exits biosimilar JV with Samsung, raising $2.3bnhttps://pharmaphorum.com/news/biogen-exits-biosimilar-jv-with-samsung-raising-2-3bn/
Merck gets EU nod for Keytruda in adjuvant kidney cancerMerck & Co has passed another milestone in its drive to move PD-1 inhibitor Keytruda earlier in the Share XMerck gets EU nod for Keytruda in adjuvant kidney cancerhttps://pharmaphorum.com/news/merck-gets-eu-nod-for-keytruda-in-adjuvant-kidney-cancer/
Biogen tweaks confirmatory trial of Alzheimer’s drug AduhelmBiogen and Eisai have expanded the size of the confirmatory trial of their Alzheimer’s drug Aduhelm in order Share XBiogen tweaks confirmatory trial of Alzheimer’s drug Aduhelmhttps://pharmaphorum.com/news/biogen-tweaks-confirmatory-trial-of-alzheimers-drug-aduhelm/
A multi-platform approach: the future of patient servicesAndy Graves and Dr Clare Moloney of IQVIA discuss how the COVID-19 pandemic accelerated the adoption of digital Share XA multi-platform approach: the future of patient serviceshttps://deep-dive.pharmaphorum.com/magazine/digital-health-2021/a-multi-platform-approach-the-future-of-patient-services/
US vs EU: How can Europe translate home-grown innovation into biotech success?We have seen a boom in biotech initial public offerings over the last two years, but many of Share XUS vs EU: How can Europe translate home-grown innovation into biotech success?https://pharmaphorum.com/r-d/us-vs-eu-translate-home-grown-innovation-into-biotech-success/
How synthetic control arms are changing clinical trialsClinical trials are involved, expensive, and have been done largely the same way for decades but with today’s Share XHow synthetic control arms are changing clinical trialshttps://pharmaphorum.com/webinars/synthetic-control-arms-ambition-to-action/
A multi-platform approach: the future of patient servicesAndy Graves and Dr Clare Moloney of IQVIA discuss how the COVID-19 pandemic accelerated the adoption of digital Share XA multi-platform approach: the future of patient serviceshttps://deep-dive.pharmaphorum.com/magazine/digital-health-2021/a-multi-platform-approach-the-future-of-patient-services/
Understanding the prevention and treatment needs for cardiovascular diseaseWhat does the current picture of cardiovascular disease in Europe look like? Surprisingly for many, cardiovascular disease (CVD) Share XUnderstanding the prevention and treatment needs for cardiovascular diseasehttps://deep-dive.pharmaphorum.com/magazine/digital-health-2021/interview-with-benoit-creveau-head-of-commercial-operations-specialty-medicines-at-daiichi-sankyo-europe/
The rise, acceleration and acceptance of telehealth adoption‘Healing at a distance’ is the literal meaning of telemedicine. According to the World Health Organization, it is Share XThe rise, acceleration and acceptance of telehealth adoptionhttps://deep-dive.pharmaphorum.com/magazine/digital-health-2021/the-rise-acceleration-and-acceptance-of-telehealth-adoption/
How synthetic control arms are changing clinical trials Share XHow synthetic control arms are changing clinical trialshttps://pharmaphorum.com/webinars/synthetic-control-arms-ambition-to-action/
Life sciences predictions for 2022 Share XLife sciences predictions for 2022https://pharmaphorum.com/webinars/life-sciences-predictions-for-2022/
Oncology treatment decisions aren’t just based on clinical data Share XOncology treatment decisions aren’t just based on clinical datahttps://pharmaphorum.com/webinars/oncology-treatment-decisions-arent-just-based-on-clinical-data/
Sales coaching: preparing for the new reality in pharmaCOVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an Share XSales coaching: preparing for the new reality in pharmahttps://pharmaphorum.com/whitepapers/pharma-sales-coaching-new-reality/
Utilising content metrics to improve digital engagementPharma companies are producing and distributing more digital content than ever due to the pandemic, meaning the content Share XUtilising content metrics to improve digital engagementhttps://pharmaphorum.com/whitepapers/content-metrics-digital-engagement-veeva/
Transform patient experience with intelligent hyper-personalisationSince 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and Share XTransform patient experience with intelligent hyper-personalisationhttps://pharmaphorum.com/whitepapers/patient-experience-personalisation-indegene/
The evolution of clinical trials: the pharmaphorum podcast Share XThe evolution of clinical trials: the pharmaphorum podcasthttps://pharmaphorum.com/video/the-evolution-of-clinical-trials/
Patient engagement processes: the pharmaphorum podcast Share XPatient engagement processes: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/patient-engagement-processes/
Digital Innovators: Wellthy Therapeutics’ Abhishek Shah Share XDigital Innovators: Wellthy Therapeutics’ Abhishek Shahhttps://pharmaphorum.com/digital/digital-innovators-wellthy-therapeutics-abhishek-shah/
6 critical success factors of a successful rapid first commercial launch Share X6 critical success factors of a successful rapid first commercial launchhttps://pharmaphorum.com/partner-content/6-critical-success-factors-of-a-successful-rapid-first-commercial-launch/
How to innovate and influence people in times of misinformation Share XHow to innovate and influence people in times of misinformationhttps://pharmaphorum.com/partner-content/how-to-innovate-and-influence-people-in-times-of-misinformation/
Formedix Partnered with CDISC to Give Free Access to CDASH-Compliant eCRFs Share XFormedix Partnered with CDISC to Give Free Access to CDASH-Compliant eCRFshttps://pharmaphorum.com/partner-content/formedix-partnered-with-cdisc-to-give-free-access-to-cdash-compliant-ecrfs/
PRISYM ID Achieves Zebra Technologies Validation Share XPRISYM ID Achieves Zebra Technologies Validationhttps://pharmaphorum.com/partner-content/prisym-id-achieves-zebra-technologies-validation/
AXON appoints Colette Balaam as its new US Managing Partner Share XAXON appoints Colette Balaam as its new US Managing Partnerhttps://pharmaphorum.com/partner-content/axon-appoints-colette-balaam-as-its-new-us-managing-partner/
Prescient Healthcare Group to Partner with Bridgepoint Development Capital Share XPrescient Healthcare Group to Partner with Bridgepoint Development Capitalhttps://pharmaphorum.com/partner-content/prescient-healthcare-group-to-partner-with-bridgepoint-development-capital/
